Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

QuidelOrtho Corporation - Common Stock (NQ: QDEL )

41.89 +0.40 (+0.96%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about QuidelOrtho Corporation - Common Stock

< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Biotech Playbook Revisited As Technicals Weaken
Recent breakthroughs with mRNA vaccines over the past two years have shown the enormous potential for transformative therapies. DNA sequencing took off five years ago and new applications are still... 
Via Talk Markets
FDA Establishes Additional Conditions Of Emergency Use Nod For COVID-19 Tests For Viral Mutations
The FDA has issued a letter to establish additional conditions of Emergency Use Authorizations (EUAs) manufacturers of COVID-19 tests. The agency has asked COVID-19... 
Via Benzinga
Exposures COVID-19 Product Safety
Why New Covid-19 Test Supplies Will Be Needed Soon in Wake of US President’s New OSHA Mandates
Via FinancialNewsMedia
Exposures COVID-19
Small Cap Biotechs Sagging But More Deals Are Likely to Perk Up the Market
Despite record highs in the Nasdaq recently at the 15,000 level the biotech market seems sluggish. Speculation has ebbed. As if we need a green screen every day. 
Via Talk Markets
Analyzing Quidel's Unusual Options Activity
On Wednesday, shares of Quidel (NASDAQ:QDEL) saw unusual o... 
Via Benzinga
Why Shares of Quidel Surged 10% This Week
Demand for its COVID tests are rising with cases. 
Via The Motley Fool
Quidel To Bring OTC COVID-19 Antigen Test To CVS Pharmacy
Quidel Corporation's (NASDAQ: QDEL) non-prescription QuickVue At-Home OTC COVID-19 Test will be available next week at CVS Pharmacy locations across... 
Via Benzinga
Exposures COVID-19
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) AbbVie Inc. (NASDAQ: ABBV... 
Via Benzinga
Exposures COVID-19 Product Safety
Quidel to Bring QuickVue® At-Home OTC COVID-19 Tests To CVS Pharmacy
From Quidel Corporation
Via Business Wire
10 Stocks For You To Review
Here are 10 stocks you asked me to analyze. Some are attractive, some are dangerously overvalued and all of them offer teaching points. 
Via Talk Markets
Return on Capital Employed Insights for Quidel
Pulled from Benzinga Pro data Quidel (NASDAQ:QDEL) posted Q2 earnings of $24.33 million, an increase from Q1 of 89.18%. Sales dropped to $176.61 million, a 52.95% decrease between... 
Via Benzinga
Healthcare Stocks Hit New Highs but Small Caps Lag
Many smaller cap biotech stocks trade on news and milestones and have no earnings so require more expertise in the field. 
Via Talk Markets
LivLyme Foundation Founder Olivia Goodreau to Discuss Perils of Lyme Disease in Free Webinar Hosted by Industry-Leading Quidel Corporation
From Quidel Corporation
Via Business Wire
84 Biggest Movers From Friday
Gainers Sphere 3D Corp. (NASDAQ: ANY) shares surged 41.3% to close at $4.86 on Friday after the company inked an agreement with turnkey mining solutions provider Hertford... 
Via Benzinga
Why Quidel Stock Was Falling on Friday
The company's Q2 headline numbers were nowhere near analyst estimates. 
Via The Motley Fool
Topics Earnings
Exposures COVID-19 Financial
55 Stocks Moving In Friday's Mid-Day Session
Gainers Sphere 3D Corp. (NASDAQ: ANY) shares jumped 29.9% to $4.47 after the company inked an agreement with turnkey mining solutions provider Hertford Advisors Ltd to provide a... 
Via Benzinga
Quidel Stock Falls As Q2 Earnings Miss Street Estimates On Lower COVID-19, Influenza Product Sales
Quidel Corporation (NASDAQ: QDEL) reported after the close of the market Thursday that its second-quarter revenues fell 12% Y/Y to $176.6 million, below the consensus... 
Via Benzinga
Topics Earnings
Exposures COVID-19 Financial
Quidel Corp (QDEL) Q2 2021 Earnings Call Transcript
QDEL earnings call for the period ending July 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Quidel Reports Second Quarter 2021 Financial Results
From Quidel Corporation
Via Business Wire
3 Reasons I Gave Up on Quidel
The company's next earnings report could be another disappointment. 
Via The Motley Fool
Exposures COVID-19
Quidel Announces Agreement With Beckman Coulter That Terminates Ongoing Litigation and Transitions BNP Business to Beckman Coulter
From Quidel Corporation
Via Business Wire
Covid-19 Tests Innovations Drawing New Interest from FDA and Consortiums
Via FinancialNewsMedia
Exposures COVID-19 Product Safety
Why Quidel Soared by Almost 8% on Monday
The company announces a potentially major testing deal in Delaware. 
Via The Motley Fool
Exposures COVID-19
State of Delaware Selects Quidel for COVID-19 Testing Program at Schools
From Quidel Corporation
Via Business Wire
Quidel to Hold Fiscal Second Quarter 2021 Financial Results Conference Call on August 5th, 2021
From Quidel Corporation
Via Business Wire
Quidel Receives CE Mark for Savanna® Multiplex Molecular Analyzer and Respiratory Viral Panel
From Quidel Corporation
Via Business Wire
New Website Created by Quidel Corporation Provides Consumers With Information and Easy-to-Understand Answers Regarding Lyme Disease
From Quidel Corporation
Via Business Wire
Quidel Recalls Lyra COVID Diagnostic Test Due To Potential False Negative Results
Quidel Corporation (NASDAQ: QDEL) is recalling its Lyra COVID-19 Assay test due to a high risk of false-negative results in patients with high amounts of the virus... 
Via Benzinga
Topics Product Recall
Exposures COVID-19 Legal Product Safety
A Review Of The 1st Half Reveals Plenty Of Great Stocks At Reasonable Prices
When you look at the market in a granular way as we did today, you begin to see patterns and trends that aren't visible on the surface. 
Via Talk Markets
The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7) Ambrx Biopharma Inc. (NYSE:... 
Via Benzinga
Topics Product Recall
Exposures COVID-19 Legal Product Safety
< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.